Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7405287
Method of treating a cancer
granted -
US 7405314
Compounds and methods for the treatment of cancer
granted -
US 7405286
Stars—A muscle-specific actin-binding protein
granted -
US 7384909
Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents
granted -
US 7378386
Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives
granted -
US 7371364
Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy
granted -
US 7368232
High-throughput assay for virus entry and drug screening
granted -
US 7365096
Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)
granted -
US 7354912
Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity
granted -
US 7348153
Method for identifying and designing immunogenic peptides
granted -
US 7344724
UspA1 and UspA2 antigens of Moraxella catarrhalis
granted -
US 7344829
Methods for detecting the efficacy of anticancer treatments
granted -
US 7338758
Compositions and methods for the identification, assessment, prevention and therapy of human cancers
granted -
US 7332469
Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
granted -
US 7332321
Viral fibers
granted -
US 7329642
β-2-glycoprotein is an inhibitor of angiogenesis
granted -
US 7319000
Compositions and methods for eliciting immune or anti-infective responses
granted -
US 7314911
Prostate hyperplasia therapy
granted -
US 7312202
Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy
granted -
US 7309692
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
granted -
US 7309792
Dimeric small molecule potentiators of apoptosis
granted -
US 7306804
HIV-specific T-cell induction
granted -
US 7303887
Mule: Mcl-1 ubiquitination ligase E3
granted -
US 7291348
Compositions and methods for biodegradable microspheres as carriers of bioactive substances
granted